1. Home
  2. GPCR vs DK Comparison

GPCR vs DK Comparison

Compare GPCR & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • DK
  • Stock Information
  • Founded
  • GPCR 2016
  • DK 2001
  • Country
  • GPCR United States
  • DK United States
  • Employees
  • GPCR N/A
  • DK N/A
  • Industry
  • GPCR
  • DK Integrated oil Companies
  • Sector
  • GPCR
  • DK Energy
  • Exchange
  • GPCR Nasdaq
  • DK Nasdaq
  • Market Cap
  • GPCR 1.1B
  • DK 1.0B
  • IPO Year
  • GPCR 2023
  • DK 2006
  • Fundamental
  • Price
  • GPCR $17.59
  • DK $20.77
  • Analyst Decision
  • GPCR Strong Buy
  • DK Hold
  • Analyst Count
  • GPCR 7
  • DK 13
  • Target Price
  • GPCR $76.17
  • DK $20.60
  • AVG Volume (30 Days)
  • GPCR 734.9K
  • DK 1.8M
  • Earning Date
  • GPCR 08-11-2025
  • DK 08-06-2025
  • Dividend Yield
  • GPCR N/A
  • DK 4.91%
  • EPS Growth
  • GPCR N/A
  • DK N/A
  • EPS
  • GPCR N/A
  • DK N/A
  • Revenue
  • GPCR N/A
  • DK $11,366,100,000.00
  • Revenue This Year
  • GPCR N/A
  • DK N/A
  • Revenue Next Year
  • GPCR N/A
  • DK N/A
  • P/E Ratio
  • GPCR N/A
  • DK N/A
  • Revenue Growth
  • GPCR N/A
  • DK N/A
  • 52 Week Low
  • GPCR $13.22
  • DK $11.03
  • 52 Week High
  • GPCR $45.37
  • DK $27.07
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 31.53
  • DK 35.62
  • Support Level
  • GPCR $17.45
  • DK $22.19
  • Resistance Level
  • GPCR $18.78
  • DK $23.74
  • Average True Range (ATR)
  • GPCR 0.82
  • DK 0.97
  • MACD
  • GPCR 0.00
  • DK -0.57
  • Stochastic Oscillator
  • GPCR 5.00
  • DK 0.73

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: